Company intelligence / Profile preview

LM Funds

Ownership: Private
Development stage: Other

Overview

LM Funds Corp. was a financial investment entity primarily known for its involvement in the life sciences sector through strategic financing and investment options. The company gained notable attention for its relationship with ViRexx Medical Corp., a Canadian development-stage biotechnology firm focused on immunotherapy for cancer and chronic viral diseases. In 2008, a planned rights offering between LM Funds and ViRexx collapsed, contributing to the latter's financial distress and subsequent acquisition by Paladin Labs. LM Funds typically operated as a vehicle for capital deployment into emerging biotech opportunities rather than conducting independent drug development.

Industry: Investors

Partnerships

ViRexx Medical Corp.

Beyond the preview

Go deeper on LM Funds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LM Funds.

Explore the full profile